Psychological complications of polycystic ovarian syndrome and women’s health
Keywords:Anxiety, Depression, Polycystic ovary, Psychological complications
Background: Polycystic Ovarian Syndrome (PCOS) affects approximately 5-10% females of reproductive age worldwide. Recent research shows that this syndrome is associated with psychological upset and devastating effects on women′s mental health and wellbeing. Lack of clinicians′ awareness of adverse psychological effects is a major concern in developing countries to provide standard care and to improve overall health outcomes.
Purpose of study was to determine the frequency of anxiety and depression among women with PCOS in order to promote awareness among clinicians about psychological complications of disease.
Methods: Present study was conducted in the department of Obstetrics and Gynaecology/ University Medical and Dental College, from October 2018 to March 2019. Sixty patients with diagnosis of PCOD and sixty participants without this disease were included in the study. Participants having other endocrine or metabolic disorders were excluded from study. Hospital anxiety and depression scale was used to detect anxiety and depression among both groups. SPSS version 16 was used for data analysis. Chi- square test was applied to compare prevalence of anxiety and depression in both groups, p-value ˂0.05 was taken as statistically significant.
Results: Women having PCOD exhibited statistically significant prevalence of anxiety (78.3% vs 35%) and depression (60% vs 30%) with p value of 0.0001 and 0.001 respectively.
Conclusions: It is highly recommended that initial evaluation of these patients should include assessment of psychological domain of disease to provide more comprehensive treatment to improve overall health related quality of life.
Sharma S, Majumdar A. Prevalence of metabolic syndrome in relation to body mass index and polycystic ovarian syndrome in Indian women. J Hum Reprod Sci. 2015;8(4):202-8.
Blay SL, Aguiar JV, Passos IC. Polycystic ovary syndrome and mental disorders: a systematic review and exploratory meta-analysis. Neuropsychiatric Dis Treatment. 2016;12:2895-903.
Shafti V, Shahbazi S. Comparing sexual function and quality of life in polycystic ovary syndrome and healthy women. J Family Reprod Health. 2016 June; 10(2): 92-8.
Rodger R, Avery J, Moore V, Davies M, Azziz R, Stener- Victorin E, et al. Complex diseases and co- morbidities: polycystic ovary syndrome and type2 diabetes mellitus. Endocr Connect. 2019March; 8(3):R71-5.
El Hayek S, Bitar L, Hamdar LH, Mirza FG, Daoud G. Poly cystic ovarian syndrome: an updated overview. Frontiers Physiol. 2016 Apr 5;7:124.
Moghadam ZB, Fereidooni B, Saffari M, Montazeri A. Measures of health-related quality of life in PCOS women: A systematic review. Inter J Women's Health. 2018;10:397-408.
Greenwood EA, Pasch LA, Cedars MI, Legro RS, Eisenberg E, Huddleston HG, et al. Insulin resistance is associated with risk of depression in polycystic ovary syndrome. Fertil Steril. 2018 Jul;110(1):27-34.
Bazarganipour F, Ziaei S, Montazeri A, Foroozanfard F, Faghihzadeh S. Iranian version of modified polycystic ovary syndrome health-related quality of Life questionnaire: Discriminant and convergent validity. Iran J Reprod Med. 2013 Sep;11(9):753-60.
Podfigurna-Stopa A, Luisi S, Regini C, Katulski K, Centini G, Meczekalski B, et al. Mood disorders and quality of life in polycystic ovary syndrome. Gynecol Endocrinol. 2015 Jun 3;31(6):431-4.
Palomba S, Santagni S, Falbo A, La Sala GB. Complications and challenges associated with polycystic ovary syndrome: current perspectives. Int J Women's Health. 2015;7:745-6.
Gul S, Zahid SA, Ansari A. PCOS: symptoms and awareness in urban Pakistani women. Int J Pharma Res Health Sci. 2014 Oct;2(5):356-60.
Dokras A, Witchel SF. Are young adult women with polycystic ovary syndrome slipping through the healthcare cracks?. J Clini Endocrinol Metab. 2014 May 1;99(5):1583-5.
Kataoka J, Tassone EC, Misso M, Joham AE, Stener-Victorin E, Teede H, et al. Weight management interventions in women with and without PCOS: a systematic review. Nutrients. 2017 Sep;9(9):996.
Ding T, Hardiman JP, Petersen I, Wang FF, Qu F, Baio G. The prevalence of polycystic ovary syndrome in reproductive- aged women of different ethnicity: a systemic review and meta- analysis. Oncotarget. 2017 Nov 10;8(56):96351- 58.
Dokras A, Stener-Victorin E, Yildiz BO, Li R, Ottey S, Shah D, et al. Androgen Excess-Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome. Fertil Steril. 2018 May 1;109(5):888-99.
Prathap A, Subhalakshmi TP, Varghese PJ. A cross-sectional study on the proportion of anxiety and depression and determinants of quality of life in polycystic ovarian disease. Ind J Psychol Med. 2018 May;40(3):257-62.
Sulaiman MA, Al- Faris YM, Al- Khaduri MM, Waly MI, Saleh J, Al-Adawi S. Psychological burden among women of polycystic ovarian syndrome in Oman: A case control study. Int J Women Health. 2017; 9: 897-904.
Sadeeqa S, Muatafa T, Latif S. Polycystic ovarian syndrome - related depression in adolescent girls: a review. J Pharm Bioallied Sci. 2018 Apr-Jun;10(2): 55-9.
Kaczmarek C, Haller DM, Yaron M. Health-related quality of life in adolescents and young adults with polycystic ovary syndrome: a systematic review. J Pediatr Adol Gynecol. 2016 Dec 1;29(6):551-7.
Scaruffi E, Gambineri A, Cattaneo S, Turra J, Vettor R, Mioni R. Personality and psychiatric disorders in women affected by polycystic ovary syndrome. Front Endocrinol. 2014 Nov 12;5:185.
Chaudhari AP, Mazumdar K, Mehta PD. Anxiety, depression and quality of life in women with polycystic ovarian syndrome. Indian J Psychol Med. 2018 May-June;40(3):239-46.
Conte F, Benting L, Teede JH, Stepto KN. Mental health and physical activity in women with polycystic ovary syndrome: A brief review. Sports Med. 2015 April;45(4):497-504.
Annagϋr BB, Kerimoglu ӦS, Tazegϋl A, Gϋndϋz Ș, Genҫoglu BB. Psychiatric comorbidity in women with polycystic ovary syndrome. J Obstet Gynaecol Res. 2015 Aug;41(8):1229-33.
Tan J, Wang QY, Feng GM, Li XY, Huang W. Increased risk of psychiatric disorders in women with polycystic ovary syndrome in Southwest China. Chinese Med J. 2017 Feb 5;130(3):262-6.
Upadhyaya SK, Sharma A, Agrawal A. Prevalence of anxiety and depression in polycystic ovarian syndrome. Int J Med Sci Pub health. 2016;5(4):681-3.
Kar S, Sanchita S. Clomiphene citrate, metformin or a combination of both as the first line ovulation induction drug for Asian Indian women with polycystic ovarian syndrome: A randomized controlled trial. J Hum Reproduce Sci. 2015 Oct;8(4):197-201.
Sulaiman HA M, Al- Faris MY, Al- Khaduri MM, Saleh J, Waley IM. Polycystic ovary syndrome is linked to increased oxidative stress to Omani women. Int J Womens Health. 2018;10:763-71.
Bazarganipour F, Taghavi AS, Montazeri A, Ahmadi F, Chaman R, Khosravi A. The impact of polycystic ovary syndrome on the health- related quality of life: A systemic review and meta - analysis. Iran J Reprod Med. 2015 Feb;13(2):61-70.
Qadri S, Hussain A, Bhat HM, Baba AA. Polycystic ovarian syndrome in bipolar affective disorder: A hospital-based study. Ind J Psychol Med. 2018Mar-Apr;40(2):121-8.
Mobini ZF, Kazemi A, Farajzadegan Z. A comprehensive mental health care program for women with polycystic ovary syndrome: protocol for a mixed methods study. Reprod Health. 2018;15:46.
Dokras A, Sarwar BD, Allison CK, Milman L, Kris- Etherton MP, Kunselman RA, et al. Weight loss and lowering androgens predict improvements in health- related quality of life in women with PCOS. J Clin Endocrinol Metab. 2016 Aug;101(8):2966-74.